Plus $8B Genmab-Merus deal, Metsera's monthly GLP-1 score, Novavax/Sanofi & Vaxcyte/Thermo shore up U.S. capacity, and AbbVie sets U.K. Elahere price to match U.S. (Sept 26–Oct 2, 2025).
Pharma Tariffs on Ice, FDA Limits Filings…
Plus $8B Genmab-Merus deal, Metsera's monthly GLP-1 score, Novavax/Sanofi & Vaxcyte/Thermo shore up U.S. capacity, and AbbVie sets U.K. Elahere price to match U.S. (Sept 26–Oct 2, 2025).